Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients

BACKGROUND: Biomarkers predicting treatment response may be used to stratify patients with pancreatic ductal adenocarcinoma (PDAC) for available therapies. The aim of this study was to evaluate the association of circulating cytokines with FOLFIRINOX response and with overall survival (OS). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Sijde, Fleur, Dik, Willem A., Mustafa, Dana A. M., Vietsch, Eveline E., Besselink, Marc G., Debets, Reno, Koerkamp, Bas Groot, Haberkorn, Brigitte C. M., Homs, Marjolein Y. V., Janssen, Quisette P., Luelmo, Saskia A. C., Mekenkamp, Leonie J. M., Oostvogels, Astrid A. M., Smits-te Nijenhuis, Marja A. W., Wilmink, Johanna W., van Eijck, Casper H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454314/
https://www.ncbi.nlm.nih.gov/pubmed/36091056
http://dx.doi.org/10.3389/fimmu.2022.898498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454314/
https://www.ncbi.nlm.nih.gov/pubmed/36091056
http://dx.doi.org/10.3389/fimmu.2022.898498

Ejemplares similares